OMER
Price:
$8.735
Market Cap:
$632.20M
Omeros Corporation is a biopharmaceutical firm with commercialized products, actively engaged in the discovery, development, and market introduction of both small-molecule and protein-based therapies, including treatments for rare diseases. The company's therapeutic endeavors primarily focus on inflammatory conditions, illnesses mediated by the complement system, cancers linked to immune system dysregulation, and disorders characterized by addiction or compulsion. Its robust clinical pipeline features several promising candidates. Narsoplimab (also known as OMS721 or MASP-2), a leading asset, has successfully concluded pivotal trials for hematopoietic stem-cell transplant-associated thrombot...[Read more]
Industry
Biotechnology
IPO Date
2009-10-08
Stock Exchange
NASDAQ
Ticker
OMER
According to Omeros Corporation’s latest financial reports and current stock price. The company's current PE Ratio is 7.66. This represents a change of 1.07% compared to the average of 0.65 of the last 4 quarters.
The mean historical PE Ratio of Omeros Corporation over the last ten years is -37.27. The current 7.66 PE Ratio has changed -2155.16% with respect to the historical average. Over the past ten years (40 quarters), OMER's PE Ratio was at its highest in in the March 2026 quarter at 3.39. The PE Ratio was at its lowest in in the September 2017 quarter at -33.42.
Average
-37.27
Median
-5.09
Minimum
-325.70
Maximum
2.99
Discovering the peaks and valleys of Omeros Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 8.79%
Maximum Annual PE Ratio = 2.99
Minimum Annual Increase = -183.11%
Minimum Annual PE Ratio = -325.70
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -325.70 | 8.79% |
| 2024 | -3.67 | 110.47% |
| 2023 | -1.74 | -158.24% |
| 2022 | 2.99 | -183.11% |
| 2021 | -3.60 | -39.20% |
| 2020 | -5.92 | -28.35% |
| 2019 | -8.26 | 93.44% |
| 2018 | -4.27 | -74.19% |
| 2017 | -16.54 | 175.22% |
| 2016 | -6.01 | -23.59% |
The current PE Ratio of Omeros Corporation (OMER) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-110.37
5-year avg
-66.34
10-year avg
-37.27
Omeros Corporation’s PE Ratio is greater than ADC Therapeutics S.A. (-1.18), greater than Neumora Therapeutics, Inc. Common Stock (-1.44), greater than Lexicon Pharmaceuticals, Inc. (-29.45), greater than RAPT Therapeutics, Inc. (-14.81), greater than Bicycle Therapeutics plc (-1.29), greater than 4D Molecular Therapeutics, Inc. (-3.74), greater than KalVista Pharmaceuticals, Inc. (-9.86), greater than Fulcrum Therapeutics, Inc. (-3.45), greater than Gossamer Bio, Inc. (-0.21), greater than Ocugen, Inc. (-5.41),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.18 | $133.55M | |
| -1.44 | $329.81M | |
| -29.45 | $852.86M | |
| -14.81 | $959.26M | |
| -1.29 | $281.05M | |
| -3.74 | $461.60M | |
| -9.86 | $1.44B | |
| -3.45 | $186.68M | |
| -0.21 | $38.00M | |
| -5.41 | $409.61M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Omeros Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Omeros Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Omeros Corporation's PE Ratio?
How is the PE Ratio calculated for Omeros Corporation (OMER)?
What is the highest PE Ratio for Omeros Corporation (OMER)?
What is the 3-year average PE Ratio for Omeros Corporation (OMER)?
What is the 5-year average PE Ratio for Omeros Corporation (OMER)?
How does the current PE Ratio for Omeros Corporation (OMER) compare to its historical average?